ICA Update, Vol.
Urge incontinence is the sudden, uncontrolled loss of urine, and can occur without warning.
The great news is that RTX may prove to be 1,000 times stronger than capsaicin, but does not cause the burning and pain that has been associated with capsaicin. It appears to work by deadening the nerve endings and desensitizing overactive nerve impulses. Afferon Corporation, which owns the rights to RTX, has presented its initial phase II clinical studies that used RTX to treat urge incontinence, and the findings look promising. Many of the patients enrolled in this study were affected with urge incontinence due to various neurological diseases, such as multiple sclerosis and spinal cord injury. The ICA does not engage in the practice of medicine.